Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 18Brain Neoplasms 8Lymphoma 6Central Nervous System Neoplasms 6Medulloblastoma 4Glioma 4Astrocytoma 4Recurrence 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, AIDS-Related 2Lung Neoplasms 2Uveal Melanoma 1Spinal Cord Neoplasms 1Solid Tumor 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Intraocular Lymphoma 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1

Interventions

Temozolomide 5Radiotherapy 2Bevacizumab 2tozuleristide 1olutasidenib 1abemaciclib 1Radiation 1Nivolumab 1Megestrol Acetate 1Lomustine 1Lapatinib 1Irinotecan 1Immunoglobulin G 1Fluorodeoxyglucose F18 1Disulfides 1Cyproheptadine 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Spinal Cord Neoplasms × Lomustine × Clear all
NCT00100802 2023-02-15

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Children's Oncology Group

Phase 2 Completed
118 enrolled 8 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡